Barclays’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-49,170
Closed -$1.95M 5418
2024
Q1
$1.95M Sell
49,170
-31,127
-39% -$918K ﹤0.01% 2592
2023
Q4
$1.53M Buy
80,297
+71,171
+780% +$989K ﹤0.01% 3125
2023
Q3
$104K Buy
9,126
+2,801
+44% +$34.5K ﹤0.01% 3587
2023
Q2
$65K Sell
6,325
-5,754
-48% -$51.9K ﹤0.01% 3725
2023
Q1
$93.3K Buy
12,079
+5,999
+99% +$47.8K ﹤0.01% 4224
2022
Q4
$44.7K Buy
6,080
+5,418
+818% +$34.6K ﹤0.01% 4587
2022
Q3
$5K Sell
662
-121
-15% -$997 ﹤0.01% 4516
2022
Q2
$7K Sell
783
-1,103
-58% -$9.51K ﹤0.01% 4730
2022
Q1
$17K Sell
1,886
-12,212
-87% -$106K ﹤0.01% 4491
2021
Q4
$196K Buy
14,098
+9,351
+197% +$116K ﹤0.01% 3575
2021
Q3
$51K Buy
4,747
+3,278
+223% +$30.2K ﹤0.01% 4107
2021
Q2
$13K Sell
1,469
-12,636
-90% -$137K ﹤0.01% 4584
2021
Q1
$150K Buy
+14,105
New +$176K ﹤0.01% 3832
2020
Q4
Sell
-2,793
Closed -$25K 5226
2020
Q3
$25K Buy
+2,793
New +$25.5K ﹤0.01% 4857
2019
Q4
Sell
-2
Closed 6943
2019
Q3
$0 Buy
+2
New +$9 ﹤0.01% 7250
2018
Q2
Sell
-134
Closed -$1K 7386
2018
Q1
$1K Buy
+134
New +$1.32K ﹤0.01% 6981
2017
Q3
Sell
-675
Closed -$6K 7116
2017
Q2
$6K Buy
+675
New +$6.47K ﹤0.01% 6202
2017
Q1
Sell
-1,000
Closed -$9K 7066
2016
Q4
$9K Hold
1,000
﹤0.01% 5953
2016
Q3
$33K Sell
1,000
-24
-2% -$584 ﹤0.01% 5225
2016
Q2
$18K Buy
1,024
+24
+2% +$426 ﹤0.01% 5322
2016
Q1
$16K Hold
1,000
﹤0.01% 5316
2015
Q4
$28K Hold
1,000
﹤0.01% 5085
2015
Q3
$48K Buy
+1,000
New +$65.7K ﹤0.01% 5031